Cargando…
Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
BACKGROUND: A decline in serum carbohydrate antigen 19-9 (CA19-9) levels during systemic chemotherapy is considered as a prognostic marker for patients with advanced pancreatic cancer. Neutrophil-to-lymphocyte ratio (NLR) has been extensively studied as a simple and useful indicator of prognosis in...
Autores principales: | Shin, Kabsoo, Jung, Eun-Kyo, Park, Se Jun, Jeong, Sangwoon, Kim, In-Ho, Lee, Myung-ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371515/ https://www.ncbi.nlm.nih.gov/pubmed/34457195 http://dx.doi.org/10.4251/wjgo.v13.i8.915 |
Ejemplares similares
-
Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019) -
Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023) -
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022) -
Association between neutrophil-to-lymphocyte ratio and major postoperative complications after carotid endarterectomy: A retrospective cohort study
por: Yu, Yun, et al.
Publicado: (2021) -
First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)